Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Diagnostics Industry Responding to Opioid Epidemic
From - Diagnostic Testing & Emerging Technologies
Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or…
Don’t Crash & Burn: Why Cutting Your Quality Department’s Budget is not a Good Idea
By Jennifer Dawson, MHA, DLM (ASCP) bio
Do you think that you can improve your organization's bottom line by reducing the budget to your quality program and cutting its staff…
Newly Proposed PAMA Rates for 2018 Confirm Lab Industry’s Worst Fears
From - National Intelligence Report
CMS's newly issued preliminary Clinical Laboratory Fee Schedule (CLFS) for 2018 dashes the lab industry's hopes for PAMA relief by making two things…
You Make the Call: Is Replacing Spoiled Products for Free an Anti-Kickback Violation?
From - G2 Compliance Advisor
The following scenario comes right out of an August 25, 2017 OIG Advisory Opinion. See if you can guess how the OIG ruled…
Fanning the Flames
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
Memorizing what actions to take in a fire situation is important, and reviewing this topic in October, National Fire Prevention Month, is both timely and…
Beware of Accidental Discrimination in Lab Job Ads
From - G2 Compliance Advisor
Before civil rights laws, job ads like these were seen as perfectly normal. Today, employers aren't allowed to post job ads with phrases that exclude or express preferences based on…